Stock NAMS FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

Real-time Estimate Tradegate
Other stock markets
 12:00:11 2024-05-15 pm EDT 		5-day change 1st Jan Change
18.4 EUR -8.96% Intraday chart for Frazier Lifesciences Acquisition Corporation -8.96% +80.93%
01:18pm TD Cowen Starts NewAmsterdam Pharma With Buy Rating MT
May. 09 Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NewAmsterdam Pharma Names Juliette Audet Chief Business Officer
MT
Newamsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
CI
Newamsterdam Pharma Insider Sold Shares Worth $4,095,234, According to a Recent SEC Filing
MT
NewAmsterdam Pharma Company N.V. Announces Board Changes
CI
NewAmsterdam Pharma Appoints Ian Somaiya as Chief Financial Officer
MT
NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer
CI
NewAmsterdam Pharma Appoints William Jones as First Chief Commercial Officer
MT
NewAmsterdam Pharma Company N.V. Appoints William ?BJ" Jones as Chief Commercial Officer
CI
NewAmsterdam Pharma Company Appoints Janneke van der Kamp to its Board of Directors
CI
NewAmsterdam Pharma Company N.V. Appoints John W. Smither as Independent Director
CI
NewAmsterdam Pharma Names David Topper CFO
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. News Frazier Lifesciences Acquisition Corporation
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW